GC Corp. (KRX:005250)
South Korea · Delayed Price · Currency is KRW 10,710
-10 (-0.09%)
Last updated: Aug 12, 2026, 2:16 PM KST
GC Corp. Market Cap
GC Corp. has a market cap or net worth of 486.71 billion as of August 11, 2026. Its market cap has decreased by -31.50% in one year.
Market Cap
486.71B
Enterprise Value
2.86T
Revenue
2.49T
Ranking
n/a
PE Ratio
n/a
Stock Price
10,710.00
ChartMarket Cap Chart
Since January 4, 1993, GC Corp.'s market cap has increased from 52.72B to 486.71B, an increase of 823.15%. That is a compound annual growth rate of 6.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 486.71B | -32.66% |
| Dec 30, 2025 | 722.80B | -8.08% |
| Dec 30, 2024 | 786.36B | 5.93% |
| Dec 28, 2023 | 742.32B | -3.82% |
| Dec 29, 2022 | 771.83B | -37.38% |
| Dec 30, 2021 | 1.23T | -34.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chabiotech | 860.27B |
| Pharmicell | 671.44B |
| Hyundai Bioscience | 655.26B |
| Onconic Therapeutics | 637.98B |
| AbClon | 558.66B |
| GI Innovation | 551.61B |
| Medy-Tox | 520.10B |
| MEDIPOST | 384.99B |